Cite

HARVARD Citation

    Panettieri Jr, R. et al. (2018). Tralokinumab for the treatment of severe, uncontrolled asthma: the ATMOSPHERE clinical development program. Immunotherapy. pp. 473-490. [Online]. 
  
Back to record